Injectable Drug Delivery Resources
-
Long-Term Container Closure Integrity Testing Of Vial-Stopper-Seal Combinations
9/3/2024
The study was designed to investigate CCI over a period of 24 months at ambient, ultra-low and cryogenic temperatures for serum-stopper samples and at ambient temperature for lyo-stopper samples.
-
Navigating PFAS "Forever Chemicals" In Medical Devices - What's On The Horizon
9/18/2024
Gain an understanding of PFAS, their properties, environmental impact, health risks, and regulatory challenges, focusing on the specific implications for the medical device industry.
-
Autoinjectors: A Revolutionary Leap In Drug Delivery
2/7/2024
Explore how the widespread adoption of autoinjectors is transforming the biopharmaceutical industry's approach to drug delivery, offering precise dosing, patient adherence, and safety.
-
Key Considerations For Packaging Solutions For Cell And Gene Therapies
Thinking of packaging and delivery factors early and often will minimize risks to the safety and efficacy of your cell and gene therapy drug product from the bench to the patient.
-
Lipids CDMO Services: Custom Excipients Tailored To Your Needs
4/27/2026
Advance your lipid‑based programs with a CDMO partner equipped to deliver customized excipients, proven scale‑up expertise, and reliable support from early development through commercialization.
-
How DFM Promotes Scalability, Repeatability, And Profitability
6/28/2024
Find out why it is critical that OEMs see and understand the benefits of taking time to build a mold or create automation more robustly to achieve long-term savings and higher annual production.
-
Prefilled Syringes Market Trends: Improving Patient Experience
6/21/2023
Learn how sterile injectable devices are providing safer and more convenient self-injection delivery, leading to positive patient experiences, better therapy adherence, and improved outcomes.
-
Key Financial Considerations For Phase II Clinical Injectable Drug Manufacturing
9/9/2022
This article highlights the importance of scalability and flexibility in the choice of an early-stage manufacturing strategy and how that decision impacts financial outcomes for a drug development program.
-
Can You Simplify Device Decisions And Stand Out From Competition?
7/25/2025
Evaluating your system’s performance and compatibility earlier in development can ensure you have a viable product to support development phases.
-
Robotics And AI In Pharma: Driving The Next Wave Of Innovation
2/23/2026
Adopting AI and robotics enhance sterility and regulatory compliance and enable real-time decision-making and reduce human-borne contamination, ensuring the safe production of complex therapies.